SEC Form 4 · accession 0001140361-18-000540
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian P McKeon
Officer — Executive VP & CFO
Period of report
Jan 1, 2018
Accepted (ET)
Jan 3, 2018 · 5:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 1, 2018 | M | 2,820 | $0.00 | A | 41,533 | D | |
| Common StockF2 | Jan 1, 2018 | F | 1,095 | $156.38 | D | 40,438 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF4,F3 | — | Jan 1, 2018 | M | 2,820 | D | — | — | Common Stock | 2,820 | 11,695 | D |
Explanation of responses
- F1Includes a total of 165 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2017, June 30, 2017, September 29, 2017 and December 29, 2017.
- F2Closing price of Issuer's common stock on the NASDAQ market on December 29, 2017.
- F3These restricted stock units are part of a grant made to the reporting person on January 1, 2014 that have vested. Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary of the date of grant. The number of restricted stock units reported was adjusted to reflect a 2-for-1 stock split in the form of a 100% stock dividend on IDEXX Laboratories, Inc. common stock paid on June 15, 2015.
- F4Not applicable.